TAGLIALATELA, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 12.715
EU - Europa 9.412
AS - Asia 3.092
SA - Sud America 721
AF - Africa 310
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 26.287
Nazione #
US - Stati Uniti d'America 12.538
RU - Federazione Russa 4.196
IE - Irlanda 1.740
SG - Singapore 1.302
CN - Cina 781
BR - Brasile 544
UA - Ucraina 538
DE - Germania 499
SE - Svezia 428
FI - Finlandia 394
IT - Italia 377
GB - Regno Unito 338
AT - Austria 230
FR - Francia 230
CI - Costa d'Avorio 201
HK - Hong Kong 180
BE - Belgio 175
IN - India 169
VN - Vietnam 166
CA - Canada 91
PL - Polonia 76
BD - Bangladesh 69
JP - Giappone 69
AR - Argentina 65
MX - Messico 56
NL - Olanda 50
TR - Turchia 44
ES - Italia 43
IQ - Iraq 42
ID - Indonesia 35
ZA - Sudafrica 34
PK - Pakistan 28
IR - Iran 26
CO - Colombia 24
CL - Cile 22
PH - Filippine 21
SA - Arabia Saudita 20
LT - Lituania 18
MY - Malesia 18
EC - Ecuador 17
VE - Venezuela 17
MA - Marocco 16
IL - Israele 15
AU - Australia 14
KR - Corea 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
JO - Giordania 13
PE - Perù 12
PY - Paraguay 12
DZ - Algeria 11
RO - Romania 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
EU - Europa 9
KZ - Kazakistan 9
CH - Svizzera 8
JM - Giamaica 8
KE - Kenya 8
AL - Albania 7
DK - Danimarca 7
ET - Etiopia 7
NZ - Nuova Zelanda 7
KG - Kirghizistan 6
GR - Grecia 5
HN - Honduras 5
HU - Ungheria 5
LB - Libano 5
MD - Moldavia 5
RS - Serbia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BY - Bielorussia 4
OM - Oman 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CR - Costa Rica 2
GE - Georgia 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
Totale 26.267
Città #
Dallas 4.063
Dublin 1.735
Moscow 1.407
Jacksonville 1.233
Chandler 1.176
San Jose 856
Singapore 690
Ashburn 475
Wilmington 420
Beijing 296
The Dalles 258
San Mateo 247
Helsinki 243
Ann Arbor 233
Vienna 221
Houston 217
Abidjan 201
Woodbridge 193
New York 187
Rome 182
Boardman 177
Brussels 174
Hong Kong 164
Princeton 163
Los Angeles 151
Lauterbourg 146
Frankfurt am Main 140
São Paulo 77
Columbus 70
Falls Church 70
Warsaw 63
Ho Chi Minh City 57
Tokyo 57
Molise 51
Santa Clara 49
Council Bluffs 43
London 43
Hillsboro 41
Chennai 39
Orem 35
Toronto 33
Redwood City 32
San Francisco 31
Brooklyn 28
Hanoi 28
Dearborn 27
Stockholm 26
Montreal 25
Munich 25
Poplar 25
Phoenix 24
Amsterdam 23
Chicago 23
Mountain View 23
Denver 22
Jakarta 22
Mexico City 22
Norwalk 22
Manchester 21
Baghdad 20
Boston 18
Da Nang 18
Johannesburg 18
Jinan 17
Nanjing 17
Ankara 16
Atlanta 16
Shenyang 16
Mumbai 14
Seoul 13
Tashkent 13
Auburn Hills 12
Augusta 12
Curitiba 12
Falkenstein 12
Naples 12
Rio de Janeiro 12
Amman 11
Dhaka 11
Kuala Lumpur 11
Kunming 11
Lahore 11
Leawood 11
Medellín 11
Napoli 11
Seattle 11
Tappahannock 11
Buenos Aires 10
Clearwater 10
Hefei 10
Brasília 9
Charlotte 9
Haikou 9
Los Altos 9
Nuremberg 9
Porto Alegre 9
Riyadh 9
Zhengzhou 9
Fortaleza 8
Guangzhou 8
Totale 17.321
Nome #
109. Involvement of the Na+-H+ antiporter on the effect of protein kinase-C activation on dopamine synthesis in rat corpus striatum 2.923
Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor α Agonist Palmitoylethanolamide 286
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 282
Consensus group on new-generation antihistamines (CONGA): present status and recommendations 251
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S-4 region of KCNQ2 causing benign familial neonatal convulsions 239
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 219
BARIUM BLOCKADE OF A CLONAL POTASSIUM CHANNEL AND ITS REGULATION BY A CRITICAL PORE RESIDUE 218
Autism and developmental disability caused by KCNQ3 gain-of-function variants 216
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 211
Adenosine receptors modulate the Na(+)-Ca2+ exchanger in cerebral nerve endings. 210
Activation of pre-synaptic M-type K+ channels inhibits [H-3]d-aspartate release by reducing Ca2+ entry through P/Q-type voltage-gated Ca(2+)channels 209
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 209
"Janus face" of nitric oxide action on plasma membrane and intracellular ionic channels 208
A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance 207
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 207
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 204
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 203
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 200
The occurrence of a Kv7.4 potassium channel in neuronal mitochondria 200
A SINGLE NONPOLAR RESIDUE IN THE DEEP PORE OF RELATED K+ CHANNELS ACTS AS A K+-RB+ CONDUCTANCE SWITCH 199
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation 199
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 198
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 198
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 197
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 195
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 192
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 191
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 189
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. 188
Cell viability studies and operation in cellular culture medium of n-type organic field-effect transistors 187
AMPA- and P2X7-receptor-mediated facilitation of [H-3]D-aspartate release from nerve terminals isolated from the rat caudal brainstem 186
Cardiotoxic effects of antihistamines: From basics to clinics (... and back) 183
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 177
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 175
Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels 172
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 172
A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha(1) subunit reduces membrane expression and impairs gating by agonists 171
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate 169
Expression, Localization, and Pharmacological Role of K(v)7 Potassium Channels in Skeletal Muscle Proliferation, Differentiation, and Survival after Myotoxic Insults 164
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 162
Protective role of Kv7 channels in oxygen and glucose deprivation-induced damage in rat caudate brain slices 161
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 159
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 159
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs 158
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neurons. 156
H-1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects 155
CORRELATING THE CLINICAL AND GENETIC FEATURES OF BENIGN FAMILIAL NEONATAL SEIZURES (BFNS) WITH THE FUNCTIONAL CONSEQUENCES OF THE UNDERLYING MUTATIONS 152
C-TERMINUS DETERMINANTS FOR MG2+ AND POLYAMINE BLOCK OF THE INWARD RECTIFIER K+ CHANNEL IRK1 152
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 147
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 147
The gene encoding a cationic amino acid transporter (SLC7A4) maps to the region deleted in the velocardiofacial syndrome 146
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 146
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 146
CYTOPLASMIC ALKALINIZATION INDUCED BY INSULIN THROUGH AN ACTIVATION OF NA+-H+ ANTIPORTER INHIBITS TYROSINE-HYDROXYLASE ACTIVITY IN STRIATAL SYNAPTOSOMES 145
Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures 143
POSSIBLE INHIBITORY ROLE OF HISTAMINE H-2 RECEPTORS IN THE CONTROL OF BASAL TSH SECRETION IN MALE-RATS - STUDIES WITH DIMAPRIT, A SELECTIVE H-2-RECEPTOR AGONIST 143
SPERMINE AND SPERMIDINE AS GATING MOLECULES FOR INWARD RECTIFIER K+ CHANNELS 141
Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A 141
K(V)7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fund 140
herg encodes a K+ current highly conserved in tumors of different histogenesis: A selective advantage for cancer cells? 140
Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species 140
EXCHANGE OF CONDUCTION PATHWAYS BETWEEN 2 RELATED K+ CHANNELS 139
VOLTAGE-DEPENDENT INHIBITION AND FACILITATION OF CA CHANNEL ACTIVATION BY GTP-GAMMA-S AND CA-AGONISTS IN ADULT-RAT SENSORY NEURONS 139
Driving with no brakes: molecular pathophysiology of kv7 potassium channels 139
COMPARISON OF H-5, S-6, AND H-5-S-6 EXCHANGES ON PORE PROPERTIES OF VOLTAGE-DEPENDENT K+ CHANNELS 138
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 138
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 137
GATING CURRENTS OF THE CLONED DELAYED-RECTIFIER K+ CHANNEL DRK1 136
Pre-synaptic BK channels selectively control glutamate versus GABA release from cortical and hippocampal nerve terminals 136
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 135
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 135
M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals 134
SPECIFICATION OF PORE PROPERTIES BY THE CARBOXYL-TERMINUS OF INWARDLY RECTIFYING K+ CHANNELS 134
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits 134
PURE UPTAKE BLOCKERS OF DOPAMINE CAN REDUCE PROLACTIN SECRETION - STUDIES WITH DICLOFENSINE 133
Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy 133
DIFFERENCES BETWEEN THE DEEP PORES OF K+ CHANNELS DETERMINED BY AN INTERACTING PAIR OF NONPOLAR AMINO-ACIDS 132
NA+-CA-2+ EXCHANGE ACTIVITY IN CENTRAL NERVE-ENDINGS .1. IONIC CONDITIONS THAT DISCRIMINATE CA-45(2+) UPTAKE THROUGH THE EXCHANGER FROM THAT OCCURRING THROUGH VOLTAGE-OPERATED CA-2+ CHANNELS 131
The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants 129
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 129
PLASMA PROLACTIN LEVELS IN THE INFERIOR PETROSAL SINUSES IN VARIOUS PITUITARY DISORDERS DURING PERIHYPOPHYSEAL PHLEBOGRAPHY 128
Gating currents from neuronal K(V)7.4 channels General features and correlation with the ionic conductance 128
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy 127
Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus 127
Up-regulation and increased activity of K(V)3.4 channels and their accessory subunit MinK-Related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death 127
Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome 126
MEMBRANE EVENTS AND IONIC PROCESSES INVOLVED IN DOPAMINE RELEASE FROM TUBEROINFUNDIBULAR NEURONS .2. EFFECT OF THE INHIBITION OF THE NA+-CA++ EXCHANGE BY AMILORIDE 126
THE NA+-CA2+ EXCHANGER ACTIVITY IN CEREBROCORTICAL NERVE-ENDINGS IS REDUCED IN OLD COMPARED TO YOUNG AND MATURE RATS WHEN IT OPERATES AS A CA2+ INFLUX OR EFFLUX PATHWAY 125
Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility 124
GADOLINIUM AND NEOMYCIN BLOCK VOLTAGE-SENSITIVE CA2+ CHANNELS WITHOUT INTERFERING WITH THE NA+-CA2+ ANTIPORTER IN BRAIN NERVE-ENDINGS 124
GATING OF INWARDLY RECTIFYING K+ CHANNELS LOCALIZED TO A SINGLE NEGATIVELY CHARGED RESIDUE 123
Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists. 123
RESCUE OF LETHAL SUBUNITS INTO FUNCTIONAL K+ CHANNELS 122
STRUCTURAL MOTIFS UNDERLYING VOLTAGE-DEPENDENT K+ CHANNEL FUNCTION 122
Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels 121
PHARMACOLOGICAL CHARACTERIZATION OF SEROTONIN RECEPTORS INVOLVED IN THE CONTROL OF PROLACTIN SECRETION 121
EVIDENCE FOR A DIFFERENTIAL INTERACTION OF BUPRENORPHINE WITH OPIATE RECEPTOR SUBTYPES CONTROLLING PROLACTIN SECRETION 121
INTERNAL AND EXTERNAL TEA BLOCK IN SINGLE CLONED K+ CHANNELS 120
Effects of manidipine and nitrendipine enantiomers on the plateau phase of K+-induced intracellular Ca2+ increase in GH(3) cells 120
REGULATION OF K+/RB+ SELECTIVITY AND INTERNAL TEA BLOCKADE BY MUTATIONS AT A SINGLE SITE IN K+ PORES 120
Totale 18.919
Categoria #
all - tutte 105.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021309 0 0 0 0 0 0 0 0 0 14 232 63
2021/20221.112 57 228 8 56 107 93 27 95 200 100 55 86
2022/20234.704 531 171 111 396 371 485 21 221 2.116 126 78 77
2023/2024786 173 85 47 15 17 150 27 100 14 51 14 93
2024/20252.553 242 93 237 106 452 121 99 217 191 71 324 400
2025/202612.929 429 1.519 2.971 539 2.706 2.210 1.134 420 329 672 0 0
Totale 26.518